Cargando…
Role of the antineoplastic drug bleomycin based on toxicogenomic-DNA damage inducing (TGx-DDI) genomic biomarkers data: A meta-analysis
OBJECTIVES: Accurately identifying the cellular, biomolecular, and toxicological functions of anticancer drugs help to decipher the potential risk of genotoxicity and other side effects. Here, we examined bleomycin for cellular, molecular and toxicological mechanisms using next-generation knowledge...
Autores principales: | Pushparaj, Peter Natesan, Rasool, Mahmood, Naseer, Muhammad Imran, Gauthaman, Kalamegam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025729/ https://www.ncbi.nlm.nih.gov/pubmed/36950431 http://dx.doi.org/10.12669/pjms.39.2.7321 |
Ejemplares similares
-
Exploration of potential molecular mechanisms and genotoxicity of anti-cancer drugs using next generation knowledge discovery methods
por: Pushparaj, Peter Natesan, et al.
Publicado: (2023) -
TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals
por: Li, Heng-Hong, et al.
Publicado: (2019) -
Editorial: In vitro toxicogenomics (TGx) in hazard and risk assessment
por: Beal, Marc A., et al.
Publicado: (2023) -
Assessment of the performance of the TGx‐DDI biomarker to detect DNA damage‐inducing agents using quantitative RT‐PCR in TK6 cells
por: Cho, Eunnara, et al.
Publicado: (2018) -
Disease associated cellular machinery in anaphylaxis – And the de novo paradigm shift
por: Pushparaj, Peter Natesan, et al.
Publicado: (2015)